Imaging for Target Volume Delineation in Rectal Cancer Radiotherapy - A Systematic Review

被引:26
|
作者
Gwynne, S. [1 ]
Mukherjee, S. [2 ]
Webster, R. [1 ]
Spezi, E. [3 ]
Staffurth, J. [4 ]
Coles, B. [5 ]
Adams, R. [4 ]
机构
[1] Velindre Canc Ctr, Dept Clin Oncol, Cardiff CF14 2TL, S Glam, Wales
[2] Univ Oxford, Gray Inst Radiat Oncol & Biol, Dept Oncol, Oxford OX1 2JD, England
[3] Velindre Canc Ctr, Dept Phys, Cardiff CF14 2TL, S Glam, Wales
[4] Cardiff Univ, Div Canc, Sch Med, Cardiff, S Glam, Wales
[5] Velindre Canc Ctr, Canc Res Wales Lib, Cardiff CF14 2TL, S Glam, Wales
关键词
CT simulation; interobserver variation; MR-CT co-registration; MRI planning; PET/CT; radiotherapy planning; rectal cancer; PREOPERATIVE CONFORMAL RADIOTHERAPY; TOTAL MESORECTAL EXCISION; TUMOR DELINEATION; PET IMAGES; POSTOPERATIVE CHEMORADIOTHERAPY; GUIDED RADIOTHERAPY; RADIATION TREATMENT; TECHNICAL ASPECTS; LOCAL RECURRENCE; LUNG-CANCER;
D O I
10.1016/j.clon.2011.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The global move towards more conformal radiotherapy for rectal cancer requires better imaging modalities that both visualise the disease accurately and are reproducible; to reduce interobserver variation. This review explores the advances in imaging modalities used in target volume delineation, with a view to make recommendations for current clinical practice and to propose future directions for research. A systematic review was conducted using MEDLINE and EMBASE. Articles considered relevant by the authors were included. Planning with orthogonal films is being replaced by computed tomography (CT) simulation. This is now considered the 'gold standard' and allows conformal three-dimensional planning. Magnetic resonance imaging (MRI) has been shown to overcome some of the limitations of CT and can be used either as a diagnostic image to visually aid planning, or as a 'planning' MRI carried out in the treatment position and co-registered with the planning CT. The latter approach has been shown to change the treated volumes compared with CT and in prostate cancer patients has been shown to reduce interobserver variation. There are remaining issues with four-dimensional motion that are yet to be fully appreciated or overcome. 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography/CT co-registered with planning CT results in smaller volumes than CT alone and also reduces interobserver variation, but requires further validation before routine implementation. Experimental work utilising novel positron emission tomography tracers and diffusion-weighted MRI shows promise and requires further evaluation. Rigorous quality assurance is important with processing of newer imaging modalities. Further work needs to be conducted into both interobserver variation and the formal evaluation of the clinical benefits of newer imaging modalities. Developments in image-guided radiotherapy are also required to ensure that improvements in target definition at the planning stage are reproducible throughout treatment. (C) 2011 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:52 / 63
页数:12
相关论文
共 50 条
  • [21] Variability of clinical target volume delineation for definitive radiotherapy in cervix cancer
    Eminowicz, Gemma
    McCormack, Mary
    RADIOTHERAPY AND ONCOLOGY, 2015, 117 (03) : 542 - 547
  • [22] The dosimetric impact of target volume delineation variation for cervical cancer radiotherapy
    Eminowicz, Gemma
    Rompokos, Vasilis
    Stacey, Christopher
    McCormack, Mary
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 (03) : 493 - 499
  • [23] Clinical target volume delineation for radiotherapy of the esophagus
    Lazarescu, I.
    Thureau, S.
    Nkhali, L.
    Pradier, O.
    Dubray, B.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 453 - 460
  • [24] Interobserver variability in target volume delineation for CT/MRI simulation and MRI- guided adaptive radiotherapy in rectal cancer
    White, Ingrid
    Hunt, Arabella
    Bird, Thomas
    Settatree, Sarah
    Soliman, Heba
    Mcquaid, Dualta
    Dearnaley, David
    Lalondrelle, Susan
    Bhide, Shree
    BRITISH JOURNAL OF RADIOLOGY, 2021, 94 (1128):
  • [25] Staging and Target Volume Delineation by 18F-FDG PET/CT in Preoperative Conformal Radiotherapy of Rectal Cancer
    Sacchetti, G.
    Baiocco, C.
    Rudoni, M.
    Leva, L.
    Anagnostou, C.
    Krengli, M.
    Inglese, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S190 - S191
  • [26] Imaging and Target Volume Delineation in Glioma
    Whitfield, G. A.
    Kennedy, S. R.
    Djoukhadar, I. K.
    Jackson, A.
    CLINICAL ONCOLOGY, 2014, 26 (07) : 364 - 376
  • [27] Impact of integrated PET/CT on variability of target volume delineation in rectal cancer
    Patel, Deep A.
    Chang, Stephanie T.
    Goodman, Karyn A.
    Quon, Andrew
    Thorndyke, Brian
    Gambhir, Sanjiv S.
    McMillan, Alex
    Loo, Billy W., Jr.
    Koong, Albert C.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2007, 6 (01) : 31 - 36
  • [28] Multidisciplinary approach to target volume delineation in recurrent rectal cancer: a pilot study
    Piqeur, Floor
    van Gruijthuijsen, Dave S. C.
    Nederend, Joost
    Ceha, Heleen
    Stam, Tanja
    Dieters, Margriet
    Meijnen, Philip
    Bakker-van der Jagt, Marjolein
    Verrijssen, An-Sofie
    Cnossen, Jeltsje S.
    Intven, Martijn
    Berbee, Maaike
    Den Hartogh, Mariska
    Bantema-Joppe, Enja J.
    de Kroon, Maaike
    Paardekooper, Gabriel
    Hurkmans, Coen
    Rutten, Harm
    Burger, Jacobus W. A.
    Marijnen, Corrie A. M.
    Peulen, Heike
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1477 - S1481
  • [29] Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer
    Koo, Taeryool
    Cheong, Kwang-Ho
    Kim, Kyubo
    Park, Hae Jin
    Park, Younghee
    Koh, Hyeon Kang
    Kim, Byoung Hyuck
    Kim, Eunji
    Kim, Kyung Su
    Choi, Jin Hwa
    PLOS ONE, 2022, 17 (09):
  • [30] Quality assurance in radiotherapy of breast cancer -: Variability in planning target volume delineation
    Pitkänen, MA
    Holli, KA
    Ojala, AT
    Laippala, P
    ACTA ONCOLOGICA, 2001, 40 (01) : 50 - 55